莫海山
【摘 要】目的 觀察A型肉毒素聯(lián)合眼袋整形術(shù)治療眼周皮膚松弛的效果。方法 選取黔南布依族苗族自治州人民醫(yī)院2020年12月-2021年12月收治的108例眼周皮膚松弛患者為研究對(duì)象,以隨機(jī)數(shù)字表法分為觀察組(54例)與對(duì)照組(54例)。對(duì)照組行眼袋整形術(shù),觀察組行A型肉毒素聯(lián)合眼袋整形術(shù),比較兩組皮膚松弛程度、治療相關(guān)指標(biāo)、不良反應(yīng)發(fā)生情況及滿(mǎn)意度。結(jié)果 兩組治療后皮膚松弛程度評(píng)分高于治療前,且觀察組高于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);觀察組皮膚色澤增強(qiáng)有效率、眼袋減輕有效率、魚(yú)尾紋減輕有效率均高于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);觀察組不良反應(yīng)發(fā)生率低于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);觀察組服務(wù)態(tài)度、治療舒適度、美觀度、操作技術(shù)、面部功能評(píng)分均高于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。結(jié)論 對(duì)眼周皮膚松弛患者實(shí)行A型肉毒素聯(lián)合眼袋整形術(shù),能有效改善皮膚松弛程度,降低不良反應(yīng)發(fā)生幾率,增強(qiáng)皮膚色澤,避免眼袋、魚(yú)尾紋癥狀再次形成,患者滿(mǎn)意度高,值得臨床應(yīng)用。
【關(guān)鍵詞】眼周皮膚松弛;A型肉毒素;眼袋整形術(shù);魚(yú)尾紋減輕有效率
中圖分類(lèi)號(hào):R779.6 文獻(xiàn)標(biāo)識(shí)碼:A 文章編號(hào):1004-4949(2023)07-0055-04
Effect of Type A Botulinum Toxin Combined with Eye Bag Plastic Surgery in the Treatment of Periocular Skin Relaxation
MO Hai-shan
(Department of Plastic Surgery, Peoples Hospital of Qiannan Buyi Miao Autonomous Prefecture, Qiannan 558000, Guizhou, China)
【Abstract】Objective To observe the effect of type A botulinum toxin combined with eye bag plastic surgery in the treatment of periocular skin relaxation. Methods A total of 108 patients with periocular skin relaxation admitted to the Peoples Hospital of Qiannan Buyi and Miao Autonomous Prefecture from December 2020 to December 2021 were selected as the research objects, and they were divided into observation group (54 cases) and control group (54 cases) by random number table method. The control group was treated with eye bag plastic surgery, and the observation group was treated with type A botulinum toxin combined with eye bag plastic surgery. The degree of skin relaxation, treatment-related indicators, adverse reactions and satisfaction were compared between the two groups. Results The skin relaxation score of the two groups after treatment was higher than that before treatment, and that in the observation group was higher than that in the control group, the difference was statistically significant (P<0.05). The effective rate of skin color enhancement, eye bag reduction and periorbital wrinkle reduction in the observation group were higher than those in the control group (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group, and the difference was statistically significant (P<0.05). The scores of service attitude, treatment comfort, aesthetics, operation technology and facial function in the observation group were higher than those in the control group, and the differences were statistically significant (P<0.05). Conclusion Type A botulinum toxin combined with eye bag plastic surgery for patients with periocular skin relaxation can effectively improve the degree of skin relaxation, reduce the incidence of adverse reactions, enhance skin color, avoid the re-formation of eye bag and periorbital wrinkle, and have high patient satisfaction, which is worthy of clinical application.
【Key words】Periorbital skin relaxation; Type A botulinum toxin; Eye bag plastic surgery; The effective rate of periorbital wrinkle reduction
眼周皮膚松弛(periocular skin relaxation)為常見(jiàn)皮膚疾病,隨著人年齡逐年增長(zhǎng),體內(nèi)新陳代謝速度緩慢,面部皮膚出現(xiàn)衰老,表現(xiàn)為出現(xiàn)皺紋、魚(yú)尾紋、眼周皮膚松弛等[1,2]?;颊叱霈F(xiàn)眼周皮膚松馳后,對(duì)五官美感影響較大,多數(shù)患者更傾向于醫(yī)學(xué)美容,如眼袋整形術(shù),但若醫(yī)生操作不當(dāng),易引發(fā)出血、感染、瘢痕、瘙癢等不良反應(yīng)[3,4]。A型肉毒素常用于美容整形領(lǐng)域,可促使表情肌松弛性麻痹,祛除額頭紋、眉間紋、魚(yú)尾紋、鼻背紋、口周紋等,通過(guò)連續(xù)2~3次注射治療,效果較佳,但也存在一定不足之處,其療效僅能維持0.5~1年,針對(duì)皮膚松弛嚴(yán)重者,效果一般[5,6]。基于此,本研究旨在分析A型肉毒素聯(lián)合眼袋整形術(shù)治療眼周皮膚松弛的臨床效果,現(xiàn)報(bào)道如下。
1.1 一般資料 選取黔南布依族苗族自治州人民醫(yī)院2020年12月-2021年12月收治的108例眼周皮膚松弛患者為研究對(duì)象,根據(jù)隨機(jī)數(shù)字表法分為觀察組和對(duì)照組,每組54例。對(duì)照組男7例,女47例;年齡40~63歲,平均年齡(50.44±1.07)歲。觀察組男6例,女48例;年齡41~62歲,平均年齡(50.38±1.14)歲。兩組性別及年齡比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05),研究可比。本研究經(jīng)醫(yī)院醫(yī)學(xué)倫理委員會(huì)審核批準(zhǔn),所有患者均知情同意,并簽署知情同意書(shū)。
1.2 納入與排除標(biāo)準(zhǔn) 納入標(biāo)準(zhǔn):①符合眼周皮膚松弛臨床診斷標(biāo)準(zhǔn)者;②臨床資料齊全者;③治療依從性較佳,配合度較高者;④對(duì)本研究藥物不過(guò)敏者;⑤無(wú)手術(shù)禁忌證者;⑥魚(yú)尾紋較深者;⑦治療前未接受過(guò)眼袋整形術(shù)者。排除標(biāo)準(zhǔn):①合并多臟器(心、腎、肝)疾病者;②合并嚴(yán)重精神疾病者;③合并感染性疾病者;④不能正常交流者;⑤妊娠期、哺乳期婦女;⑥合并血液系統(tǒng)疾病者;⑦凝血功能障礙者。
1.3 方法
1.3.1對(duì)照組 行眼袋整形術(shù):于眼瞼緣據(jù)睫毛根部 0.3 cm左右作一切口,以外眥角為另一切口,沿切口方向逐層分離眼輪匝肌,完全暴露眶隔筋膜,切除眼瞼處多余脂肪組織;以蚊式血管鉗對(duì)眼輪匝肌外側(cè)深面處進(jìn)行剝離,完全暴露主韌帶,從中間切斷,固定下眼瞼,用選擇3-0線(xiàn)針對(duì)眶外緣骨膜和韌帶進(jìn)行縫合。針對(duì)術(shù)中眶隔脂肪疝未存在嚴(yán)重突出但下眶緣溝、眶鼻溝顯著凹陷者,保留眶隔,剝離脂肪,下移眶隔筋膜,對(duì)下眶緣4~5 mm處的骨膜進(jìn)行固定。針對(duì)部分松弛下瞼皮膚、眼輪匝肌,可進(jìn)行切除;針對(duì)術(shù)中切除的眶隔脂肪填充凹陷的外眥,常規(guī)手術(shù)操作即可,后對(duì)其進(jìn)行縫合處理。
1.3.2觀察組 行A型肉毒素聯(lián)合眼袋整形術(shù):眼袋整形術(shù)方法同對(duì)照組,為患者注射A型肉毒素(蘭州生物制品研究所有限責(zé)任公司,國(guó)藥準(zhǔn)字S10970037,規(guī)格:50 U、100 U),位置選擇:①眼角平行外移2 cm;②眼角外側(cè)上方1 cm;③眼角外側(cè)1 cm;④眼角外側(cè)下方1 cm。皮下肌層注射,劑量2.5 U,注射時(shí)需要避開(kāi)患者血管。
1.4 觀察指標(biāo) 比較兩組治療指標(biāo)、不良反應(yīng)發(fā)生率、皮膚松弛程度、滿(mǎn)意度。①治療指標(biāo):包括皮膚色澤增強(qiáng)、眼袋減輕、魚(yú)尾紋減輕3項(xiàng)指標(biāo)的改善情況;②不良反應(yīng)發(fā)生率:統(tǒng)計(jì)出現(xiàn)切口瘢痕、切口紅腫、切口滲液、術(shù)眼紅腫的情況;③皮膚松弛程度:以我院自制量表進(jìn)行評(píng)估,分值為0~20分,分值越低,皮膚越松弛;④滿(mǎn)意度:以我院自制量表進(jìn)行評(píng)分,評(píng)價(jià)患者對(duì)治療效果的滿(mǎn)意度,量表內(nèi)容包括服務(wù)態(tài)度、治療舒適度、美觀度、操作技術(shù)、面部功能,總分0~100分,分值越高,表示患者越滿(mǎn)意。
1.5 統(tǒng)計(jì)學(xué)方法 應(yīng)用SPSS 24.0統(tǒng)計(jì)學(xué)軟件分析本研究數(shù)據(jù),符合正態(tài)分布的計(jì)量資料以(x-±s)表示,行t檢驗(yàn);計(jì)數(shù)資料以[n(%)]表示,行χ2檢驗(yàn);以P<0.05為差異有統(tǒng)計(jì)學(xué)意義。
2.1 兩組皮膚松弛程度比較 兩組治療后皮膚松弛程度評(píng)分高于治療前,且觀察組高于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05),見(jiàn)表1。
2.2 兩組治療指標(biāo)比較 觀察組皮膚色澤增強(qiáng)、眼袋減輕、魚(yú)尾紋減輕改善程度均高于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05),見(jiàn)表2。
2.3 兩組不良反應(yīng)發(fā)生率比較 觀察組不良反應(yīng)發(fā)生率低于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05),見(jiàn)表3。
2.4 兩組滿(mǎn)意度比較 觀察組服務(wù)態(tài)度、治療舒適度、美觀度、操作技術(shù)、面部功能評(píng)分均高于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05),見(jiàn)表4。